Literature DB >> 11324770

Combined radiation therapy and chemotherapy for carcinoma of the cervix.

P G Rose1, P J Eifel.   

Abstract

Cervical cancer is the third most common cancer affecting women worldwide. Surgery, radiation therapy, and chemotherapy have been used in various settings in an effort to improve survival rates of patients with cervical cancer. Recent cooperative clinical trials have demonstrated a benefit from the concurrent use of chemotherapy and radiation therapy to treat cervical cancer. These studies have provided the most significant improvement in the treatment of locally advanced disease in more than 30 years. This review summarizes studies of sequential and concurrent combinations of chemotherapy and radiation therapy for the treatment of cervical cancer, as well as the recent controversies related to this treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11324770

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  2 in total

1.  A randomized phase II evaluation of bryostatin-1 (NSC #339555) in persistent or recurrent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group Study.

Authors:  Deborah K Armstrong; John A Blessing; Janet Rader; Joel I Sorosky
Journal:  Invest New Drugs       Date:  2003-11       Impact factor: 3.850

2.  Neuropilin-1 expression identifies a subset of regulatory T cells in human lymph nodes that is modulated by preoperative chemoradiation therapy in cervical cancer.

Authors:  Alessandra Battaglia; Alexia Buzzonetti; Giovanni Monego; Laura Peri; Gabriella Ferrandina; Francesco Fanfani; Giovanni Scambia; Andrea Fattorossi
Journal:  Immunology       Date:  2007-11-20       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.